
How Pharma Marketers Can Prepare for Trump’s 200% Tariff Threat
Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility.
Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility.
The longer we delay, the further we shift costs from polluters to patients — and to every taxpayer who funds Medicare, Medicaid and community hospitals. Environmental stewardship and human health are inseparable; regulating microplastics is preventive medicine on a national scale.
The bill clarifies very specific patient protections and codifies a Patient’s Bill of Rights, all of which would ensure that individuals receiving supplemental oxygen in the home – and their suppliers – understand requirements around equipment, communications, and care options.
In the race to modernize US healthcare, Donald Trump’s new health data-sharing initiative risks giving Big Tech a stranglehold over patient information, and locking out the very startups that fuel innovation.
We need a national strategy to expand access to palliative care, train the next generation of clinicians, and build the infrastructure that allows for scalable, tech-enabled, patient-centered delivery.
If we truly believe in treating the whole patient, we must recognize that survival is not the only measure of success. Preserving a woman’s sense of self, her dignity, her identity, her autonomy is just as essential.
Now, with the ability to measure coronary inflammation through AI-enhanced CT scans and to more accurately determine a person's risk of heart attack, we can intervene earlier and more effectively.
His longstanding anti-vaccine rhetoric and vocal opposition to science-backed expert consensus has caused widespread concern among public health and medical professionals about the appropriateness of his leadership.
With the global market for anti-obesity drugs projected to hit $95 billion by 2030, it’s no surprise that compounded semaglutide is gaining traction as a cheaper, more accessible option. But for all its appeal, this route comes with real risks: regulatory uncertainty, legal exposure, and major insurance hurdles.
By unlocking the benefits of AI in healthcare, the industry can stabilize the unbalanced supply and demand caused by limited resources and aging global populations.
As manufacturers play an active role in the patients’ healthcare journey, the boundaries between manufacturers and healthcare providers/payers are becoming increasingly blurry.
If we gut school-based care, we’re not only closing doors, we’re also deepening the racial and economic inequities that already shape our mental health system. We can’t claim to care about equity in healthcare if we’re willing to strip care from the very places that reach the kids who need it most.
The current system is failing vulnerable patients – those it was designed to help. While well-intentioned, the savings these programs promise rarely trickle down to patients.
White bagging not only creates significant uncompensated administrative burden and scheduling challenges for providers, but it also delays or limits access to necessary medication for patients.
The Train More Nurses Act would help address these challenges by directing the U.S. Department of Health and Human Services (HHS), as well as the U.S. Labor Department, to conduct a review of nursing grant programs to identify opportunities to increase faculty at nursing schools nationwide, especially in underserved communities.